Literature DB >> 27530825

National Trends in Hospitalizations of Adults With Tetralogy of Fallot.

Ada C Stefanescu Schmidt1, Doreen DeFaria Yeh1, Sara Tabtabai1, Kevin F Kennedy2, Robert W Yeh3, Ami B Bhatt4.   

Abstract

The population of adults with tetralogy of Fallot (TOF) is growing, and it is not known how the changes in age distribution, treatment strategies, and prevalence of co-morbidities impact their interaction with the health care system. We sought to analyze the frequency and reasons for hospital admissions over the past decade. We extracted serial cross-sectional data from the United States Nationwide Inpatient Sample on hospitalizations including the diagnostic code for TOF from 2000 to 2011. From 2000 to 2011, there were 20,545 admissions for subjects with TOF, with a steady increase in annual number. The most common primary admission diagnoses were heart failure (HF; 17%), arrhythmias (atrial 10% and ventricular 6%), pneumonia (9%), and device complications (7%). The rates of co-morbidities increased significantly, particularly diabetes (4.5% to 8.1%), obesity (2.1% to 6.5%), hypertension, and renal disease. The number of pulmonic valve replacements increased (6.8% to 11.3% of TOF admissions, p <0.001), with an increase in median age at surgery from 16 to 19 years old (p = 0.036). The cost per TOF admission was more than double that of noncongenital HF admissions and rose significantly, reaching $21,800 ± 46,000 in 2011. In conclusion, hospitalized patients with TOF have become significantly more medically complex and are growing in number. The increase in the prevalence of obesity, hypertension, and diabetes in this young population supports the need for prevention efforts focused on modifiable risk factors, in addition to HF and arrhythmia treatment. The increase in cost of care calls for further analysis of areas in which efficiency can be increased to ensure high quality of care and lifelong follow-up of patients with TOF.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27530825      PMCID: PMC5349299          DOI: 10.1016/j.amjcard.2016.06.034

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  25 in total

1.  Coronary artery bypass operations for elderly patients in California, 2003 to 2008.

Authors:  Zhongmin Li; Ezra A Amsterdam; Khung Keong Yeo; Holly Hoegh; Geeta Mahendra; W Douglas Boyd; J Nilas Young
Journal:  Ann Thorac Surg       Date:  2012-02-22       Impact factor: 4.330

2.  Pulmonary valve replacement late after repair of tetralogy of Fallot.

Authors:  I M Yemets; W G Williams; G D Webb; D A Harrison; P R McLaughlin; G A Trusler; J G Coles; I M Rebeyka; R M Freedom
Journal:  Ann Thorac Surg       Date:  1997-08       Impact factor: 4.330

3.  Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study.

Authors:  M A Gatzoulis; S Balaji; S A Webber; S C Siu; J S Hokanson; C Poile; M Rosenthal; M Nakazawa; J H Moller; P C Gillette; G D Webb; A N Redington
Journal:  Lancet       Date:  2000-09-16       Impact factor: 79.321

4.  The challenge of congenital heart disease worldwide: epidemiologic and demographic facts.

Authors:  Pierre-Luc Bernier; Ada Stefanescu; Gordan Samoukovic; Christo I Tchervenkov
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2010

5.  Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery.

Authors:  Kambiz Norozi; Armin Wessel; Valentin Alpers; Jan Ole Arnhold; Siegfried Geyer; Monika Zoege; Reiner Buchhorn
Journal:  Am J Cardiol       Date:  2006-03-03       Impact factor: 2.778

6.  Trends in hospitalizations for adults with congenital heart disease in the U.S.

Authors:  Alexander R Opotowsky; Omar K Siddiqi; Gary D Webb
Journal:  J Am Coll Cardiol       Date:  2009-07-28       Impact factor: 24.094

7.  Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease.

Authors:  Konstantinos Dimopoulos; Gerhard-Paul Diller; Evdokia Koltsida; Antonia Pijuan-Domenech; Sofia A Papadopoulou; Sonya V Babu-Narayan; Tushar V Salukhe; Massimo F Piepoli; Philip A Poole-Wilson; Nicky Best; Darrel P Francis; Michael A Gatzoulis
Journal:  Circulation       Date:  2008-04-28       Impact factor: 29.690

8.  Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death.

Authors:  M A Gatzoulis; J A Till; J Somerville; A N Redington
Journal:  Circulation       Date:  1995-07-15       Impact factor: 29.690

9.  Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort.

Authors:  Anne Marie Valente; Kimberlee Gauvreau; Gabriele Egidy Assenza; Sonya V Babu-Narayan; Jenna Schreier; Michael A Gatzoulis; Maarten Groenink; Ryo Inuzuka; Philip J Kilner; Zeliha Koyak; Michael J Landzberg; Barbara Mulder; Andrew J Powell; Rachel Wald; Tal Geva
Journal:  Heart       Date:  2013-10-31       Impact factor: 5.994

10.  Clinical outcomes of surgical pulmonary valve replacement after repair of tetralogy of Fallot and potential prognostic value of preoperative cardiopulmonary exercise testing.

Authors:  Sonya V Babu-Narayan; Gerhard-Paul Diller; Radu R Gheta; Anthony J Bastin; Theodoros Karonis; Wei Li; Dudley J Pennell; Hideki Uemura; Babulal Sethia; Michael A Gatzoulis; Darryl F Shore
Journal:  Circulation       Date:  2013-10-21       Impact factor: 29.690

View more
  3 in total

1.  Lifetime Burden of Adult Congenital Heart Disease in the USA Using a Microsimulation Model.

Authors:  Cynthia L Gong; Henu Zhao; Yifan Wei; Bryan Tysinger; Dana P Goldman; Roberta G Williams
Journal:  Pediatr Cardiol       Date:  2020-07-10       Impact factor: 1.655

2.  Clinical Genetic Risk Variants Inform a Functional Protein Interaction Network for Tetralogy of Fallot.

Authors:  Miriam S Reuter; Rajiv R Chaturvedi; Rebekah K Jobling; Giovanna Pellecchia; Omar Hamdan; Wilson W L Sung; Thomas Nalpathamkalam; Pratyusha Attaluri; Candice K Silversides; Rachel M Wald; Christian R Marshall; Simon G Williams; Bernard D Keavney; Bhooma Thiruvahindrapuram; Stephen W Scherer; Anne S Bassett
Journal:  Circ Genom Precis Med       Date:  2021-07-30

3.  Hospitalization Trends and Health Resource Use for Adult Congenital Heart Disease-Related Heart Failure.

Authors:  Luke J Burchill; Lina Gao; Adrienne H Kovacs; Alexander R Opotowsky; Bryan G Maxwell; Jessica Minnier; Abigail M Khan; Craig S Broberg
Journal:  J Am Heart Assoc       Date:  2018-08-07       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.